BTAI · BioXcel Therapeutics, Inc.
$0.89
-0.30 (-25.21%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's history of significant losses, its negative cash flows from operations, its current debt obligations, potential near-term increased covenant-driven amortization payments under its Credit Agreement, its limited liquidity resources currently on hand, and its dependence on its ability to obtain additional financing to fund its operations after the current resources are exhausted, about which there can be no certainty, have resulted in management's assessment that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least 12 months from the issuance date of the financial statements included in this Quarterly Report. Although the Company has developed and implemented certain plans, they will not mitigate the entity's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$28.59M
Shares
31.31M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-20 | Mehta Vimal | Officer | 19,419 | 2026-05-20 | Merrill Lynch |
| 2026-05-20 | Rodriguez Javier | Officer | 6,560 | 2026-05-20 | Merrill Lynch |
| 2026-05-20 | Yocca Frank | Officer | 6,845 | 2026-05-20 | Merrill Lynch |
| 2026-05-20 | Steinhart Richard I | Officer | 6,845 | 2026-05-20 | Merrill Lynch |
| 2024-12-16 | O'Neill Vincent | Officer | 165 | 2024-12-16 | Merrill Lynch |
| 2024-12-16 | Steinhart Richard I | Officer | 438 | 2024-12-16 | Merrill Lynch |
| 2024-12-16 | Mehta Vimal | Officer | 983 | 2024-12-16 | Merrill Private Wealth Management |
| 2024-12-16 | Rodriguez Javier | Officer | 430 | 2024-12-16 | Merrill Lynch |
| 2024-12-16 | Yocca Frank | Officer | 430 | 2024-12-16 | Merrill Lynch |
| 2024-10-03 | Rodriguez Javier | Officer | 6,863 | 2024-10-03 | Merrill Lynch |
| 2024-10-03 | Wiley Matthew T. | Officer | 6,272 | 2024-10-03 | Merrill Lynch |
| 2024-10-03 | Steinhart Richard I | Officer | 7,175 | 2024-10-03 | Merrill Lynch |
| 2024-10-03 | Yocca Frank | Officer | 7,175 | 2024-10-03 | Merrill Lynch |
| 2024-10-03 | O'Neill Vincent | Officer | 5,556 | 2024-10-03 | Merrill Lynch |
| 2024-09-16 | Rodriguez Javier | Officer | 345 | 2024-09-16 | Merrill Lynch |
| 2024-09-16 | Steinhart Richard I | Officer | 356 | 2024-09-16 | Merrill Lynch |
| 2024-09-16 | Yocca Frank | Officer | 355 | 2024-09-16 | Merrill Lynch |
| 2024-09-16 | Mehta Vimal | Officer | 832 | 2024-09-16 | Merrill Private Wealth Management |
| 2024-09-16 | O'Neill Vincent | Officer | 138 | 2024-09-16 | Merrill Lynch |
| 2024-09-16 | Wiley Matthew T. | Officer | 215 | 2024-09-16 | Merrill Lynch |
| 2024-06-17 | O'Neill Vincent | Officer | 155 | 2024-06-17 | Merrill Lynch |
| 2024-06-17 | Rodriguez Javier | Officer | 361 | 2024-06-17 | Merrill Lynch |
| 2024-06-17 | Wiley Matthew T. | Officer | 244 | 2024-06-17 | Merrill Lynch |
| 2024-06-17 | Yocca Frank | Officer | 372 | 2024-06-17 | Merrill Lynch |
| 2024-06-17 | Mehta Vimal | Officer | 1,225 | 2024-06-17 | Merrill Private Wealth Management |
| 2024-06-17 | Steinhart Richard I | Officer | 372 | 2024-06-17 | Merrill Lynch |
| 2024-06-04 | BioXcel LLC | 10% Stockholder | 252,028 | 2024-06-04 | Merrill Private Wealth Management |
| 2024-04-04 | Wiley Matthew T. | Officer | 1,008 | 2024-04-04 | Merrill Lynch |
| 2024-04-04 | Rodriguez Javier | Officer | 1,012 | 2024-04-04 | Merrill Lynch |
| 2024-04-04 | O'Neill Vincent | Officer | 165 | 2024-04-04 | Merrill Lynch |
| 2024-04-04 | Yocca Frank | Officer | 1,067 | 2024-04-04 | Merrill Lynch |
| 2024-04-04 | Steinhart Richard I | Officer | 1,069 | 2024-04-04 | Merrill Lynch |
| 2024-04-04 | Mehta Vimal | Officer | 829 | 2024-04-04 | Merrill Private Wealth Management |
| 2023-09-20 | Mueller Family 2010 Irrevocable Trust | Affiliate | 2,500 | 2023-09-20 | Cowen and Company LLC |
| 2023-09-20 | MUELLER PETER | Officer | 96,993 | 2023-09-20 | Cowen and Company LLC |
| 2023-09-20 | Peter Mueller 2018 Irrevocable Family Trust | affilaite | 112,802 | 2023-09-20 | cowen and company llc |
| 2023-06-20 | Mueller Family 2010 Irrevocable Trust | Affiliate | 2,500 | 2023-06-20 | Cowen and Company, LLC |
| 2023-06-20 | MUELLER PETER | Officer | 96,993 | 2023-06-20 | Cowen & Company, LLC |
| 2023-06-20 | Peter Mueller 2018 Irrevocable Family Trust | Affiliate | 112,802 | 2023-06-20 | Cowen and Company, LLC |
| 2023-06-15 | Mehta Vimal | Officer | 60,000 | 2023-06-15 | Merrill Private Wealth Management |
| 2023-05-22 | Mehta Vimal | Officer | 6,500 | 2023-05-22 | Merrill Lynch |
| 2023-05-15 | Rodriguez Javier | Officer | 1,785 | 2023-05-15 | Merrill Lynch |
| 2023-05-15 | Steinhart Richard I | Officer | 5,000 | 2023-05-15 | Merrill Lynch |
Showing 1–43 of 43 filings
Key facts
CIK
1720893
CUSIP
09075P204
13F (30d)
46 filings
46 filers
Visit website
Investor relations